Skip to content

Evaluation of the advantages of sprayable endotracheal catheter in anesthesia management for craniocerebral and spinal surgery and early postoperative rehabilitation: a multicentre, evaluator blinded, randomized, controlled clinical trial

Evaluation of the advantages of sprayable endotracheal catheter in anesthesia management for craniocerebral and spinal surgery and early postoperative rehabilitation: a multicentre, evaluator blinded, randomized, controlled clinical trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036912
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse reactions during endotracheal intubation and extubation

Interventions

experimental group:Local anesthesia is performed through a spray tracheal tube
control group:Common tracheal

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age from 18 to 75 years old, regardless of gender; 2. Patients diagnosed with craniocerebral or spinal tumors are scheduled to undergo general anesthesia for tumor resection; 3. Body mass index (BMI) measure of 18.5 kg/m2 < BMI <= 30 kg/m2; 4. ASA classification is I–III; 5. The informed consent shall be agreed and signed by the ETHICS Committee.

Exclusion criteria

Exclusion criteria: 1. The heart, kidney, liver and other important organs function is not complete; 2. Respiratory dysfunction; 3. Prior use of beta blockers, digoxin, alpha agonists or psychotropic drugs; 4. Heart rate less than 60 times/min or blood pressure less than 100/60mmhg; 5. Previous history of allergy; 6. II or III-degree atrioventricular block; 7. Pregnant/lactating women; 8. Morbidly obese people.

Design outcomes

Primary

MeasureTime frame
A comprehensive assessment of adverse events during intubation and extubation;

Secondary

MeasureTime frame
Cortisol;Extubation time;

Countries

China

Contacts

Public ContactYuan Lan

Department of Anesthesiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

yuanlansan@htomail.com+86 13601789799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026